| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.3 | 9e-17 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |